HB 2939 creates a state income tax credit for businesses expanding or locating qualified facilities in Arizona. It directly affects businesses that make new capital investments, create qualifying jobs paying at least 125% of the median wage (100% in rural areas), and provide 65% employer-paid health insurance. The credit equals 10% of qualifying investments, capped at $200,000-$300,000 per new job, with a $125 million annual cap and $30 million per business limit. Businesses must retain operations at the facility for five years and claim credits in five equal installments over time.
HB 2202 appropriates $300,000 annually from 2026-2029 to fund a dementia care telementoring program for Arizona healthcare providers. The program, administered by the Department of Health Services, will provide virtual mentoring sessions focused on dementia detection, diagnosis, and care management, with priority for rural and underserved communities. Grant recipients must offer case-based sessions, continuing education credits, and report participation data. The program expires December 31, 2029, after which the funding will no longer be available.
This Arizona bill (HB 2364) bans mailing, shipping, or delivering abortion-inducing drugs via courier, delivery, or mail services. It makes selling such drugs through these methods a class 5 felony (or class 4 for healthcare workers acting in their job), and receiving them this way a class 1 misdemeanor. The law specifically excludes drugs prescribed for non-abortion medical purposes. It defines "abortion-inducing drug" as any substance used for medication abortion.
HB 2051 adds breastfeeding and lactation care services - including consultations, education, and counseling - as a covered benefit under Arizona's AHCCCS (Medicaid) program. This applies directly to AHCCCS enrollees, including new mothers, who need support in inpatient, outpatient, home-based, or group settings. The bill amends existing law to explicitly include these services under covered health and medical services without changing current coverage limits or funding. It does not alter other benefits or eligibility requirements for the program.
HB 2402 requires ambulance services in Arizona to submit detailed operational data quarterly to the state department, including dispatch times, on-scene response times, ambulance availability, mutual aid requests, and patient injury reports. This applies directly to all ambulance service providers operating within the state. The department must publicly post this information (with personal details redacted) on its website and may impose a $500 civil penalty for failure to comply with reporting requirements. The bill focuses on increasing transparency around ambulance service performance rather than altering service standards or emergency protocols.
HB 2444 allows Arizona pharmacists to independently order, perform, and interpret certain FDA-waived tests (like flu, strep, or COVID-19 tests) and initiate treatment for specific conditions - including influenza, strep throat, HIV prevention, and other public health threats - without a physician's direct order. It directly affects pharmacists (who gain new clinical authority) and patients aged six or older who need treatment for those conditions. Key provisions require pharmacists to follow a statewide protocol covering documentation, referrals, patient screening, and evidence-based guidelines, while mandating notification to a patient’s primary care provider within 72 hours of treatment. The bill also prohibits pharmacists from prescribing opioids or treating minors without parental consent.
HB 2437 establishes Arizona’s participation in the Emergency Medical Services (EMS) Licensure Interstate Compact. It allows Arizona-licensed EMTs, AEMTs, and paramedics to practice temporarily in other participating states without obtaining new licenses, while ensuring public safety through standardized requirements. To maintain reciprocity, Arizona must require national registry exams (NREMT), have complaint investigation systems, conduct background checks for new licenses, and share adverse action information with the compact’s commission. This directly affects EMS personnel who work across state lines, including military members and their spouses transitioning to civilian roles. The bill creates a framework for mutual recognition but does not change Arizona’s existing licensure rules for in-state practice.
HB 2188 establishes a state grant program to provide language acquisition services for infants and toddlers who are deaf or hard of hearing in Arizona. The program, administered by the state department, funds listening and spoken language services through contracted providers and requires referrals to both the grant program and the Arizona State Schools for the Deaf and the Blind for American Sign Language (ASL) and other language options. Families accessing early intervention services must be directed to these resources. The bill directly affects families with young children who are deaf or hard of hearing, aiming to expand access to language development support through specific service referrals and state-funded grants.
HB 2224 allocates $2 million annually from Arizona's state general fund starting in fiscal year 2026-2027 to the Department of Economic Security for its existing produce incentive program. The bill directly affects the Department of Economic Security, which administers the program, and would impact eligible Arizona residents who use the program's incentives to purchase fresh produce. The funding is exempt from standard appropriation lapsing rules, ensuring consistent annual support. This is a procedural budgetary measure, not a policy change, as it only provides funding for an already-established program.
HB 2697 allows pharmacists, health departments, and healthcare providers to dispense or distribute expired FDA-approved naloxone (an opioid overdose reversal medication) to individuals at risk of overdose, their families, or community organizations that assist them. The bill defines "expired opioid antagonist" as medication with an expiration date within five years of use, expanding access to this critical tool. It provides immunity from liability for professionals acting in good faith while following protocols, including instructing users to call emergency services after administration. This policy directly affects people at risk of opioid overdose, pharmacists, healthcare providers, and community health programs distributing naloxone.
